THERAPEUTIC COMPOSITIONS FOR BOOSTING THE EFFECT OF ANTIBODY THERAPY AGAINST THE EPIDERMAL GROWTH FACTOR RECEPTOR
摘要
<p>The present invention describes specific therapeutic compositions which increase the effectiveness of monoclonal antibody (mAb) therapy against the epidermal growth factor receptor (EGFR) and type-I (α/ß) interferons (IFNs).</p>
